# The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians

> **NCT03819790** · PHASE4 · COMPLETED · sponsor: **LMC Diabetes & Endocrinology Ltd.** · enrollment: 119 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Basal insulin glargine and lixisenatide
- **DRUG:** Basal insulin Basaglar/Lantus + gliclazide MR
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT03819790
- **Lead sponsor:** LMC Diabetes & Endocrinology Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-02
- **Primary completion:** 2019-11-19
- **Final completion:** 2019-11-19
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2021-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03819790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03819790, "The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03819790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*